Abstract
A new era in the treatment of disorders of bone began about 45 years ago with the introduction of BP into clinical practice. BPs are deposited on the surface of the bones and inhibit osteoclasts and thus resorption of bone. Consequently these drugs have long been given to patients with Morbus Paget, with hypercalcaemia, with multiple myeloma and with osseous metastases. BPs not only inhibit resorption of bone, but they also inhibit growth of metastases in bone and marrow.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bartl, R., Bartl, C. (2019). Bisphosphonates (BPs). In: The Osteoporosis Manual. Springer, Cham. https://doi.org/10.1007/978-3-030-00731-7_24
Download citation
DOI: https://doi.org/10.1007/978-3-030-00731-7_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00730-0
Online ISBN: 978-3-030-00731-7
eBook Packages: MedicineMedicine (R0)